University of Lausanne
Lausanne, Canton of Vaud, 1005, Switzerland
NCT Number: NCT01610986
The purpose of this study is to determine whether glucose-fructose intake during training increases lactate transport and oxidation and improve endurance performance.
Looking for future studies?
Notify Me18 year–30 year
Male
Interventional
Not applicable
Lausanne, Canton of Vaud, 1005, Switzerland
The study will enroll 24 healthy male volunteers. After baseline assessment of lactate transport and endurance performance, subjects will be randomized to either a 3-week intervention arm in which they will train with glucose-fructose intake during training, or to a control arm (water during training). After this 3-week intervention, lactate transport and endurance performance will be assessed again.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
0.8 g/h glucose and 0.5 g/h fructose during training
Only water intake during training
Time frame: At baseline (before training) and after the 3-week training protocol
Measurement of lactate production, utilization, oxidation and clearance during a 90 min cycling exercise at 50% VO2 max (measured with 13C-lactate)
Time frame: At baseline (before training) and after the 3-week training protocol
MCTs expression (mRNA) and protein content after muscle biopsy
University of Lausanne
Other
Effects of Glucose-fructose Drinks During Training on Lactate Transport and Oxidation and on Endurance Performance
Acronym: LactEx
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05364372
Behavior, Cancer
Tucson, Arizona, United States
View Trial DetailsNCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT07597460
Behavior, Child Health
Santiago, Chile
View Trial DetailsNCT05870072
Balance, Postural, Behavior
Kütahya, Centre, Turkey (Türkiye)
View Trial Details